Literature DB >> 27553815

Successful scleral buckling of late-onset visual decrease in eye with retinal folds.

Yuri Nakayama1, Satoshi Katagiri1,2, Tadashi Yokoi1, Makiko Ui1, Sachiko Nishina1, Noriyuki Azuma3.   

Abstract

PURPOSE: To describe the outcome of scleral buckling to treat radial retinal folds (RFs) that caused a late-onset and sudden visual decrease with impairment of the fovea.
METHODS: This is an observational case report. Ophthalmic examinations were performed preoperatively and postoperatively and included measurement of the best-corrected visual acuity (BCVA), fundus examination, fluorescein angiography, focal macular electroretinography (FM-ERG), and spectral-domain optical coherence tomography (OCT).
RESULTS: A patient, whose case was reported previously, had a superonasal retinal detachment with a dislocated fovea and good BCVA in her right eye and a sustained BCVA of 40/50 by age 17 years and 3 months. The BCVA decreased suddenly to 20/200 at age 17 years and 11 months. Fundus examinations showed micro-dislocation of the fovea to the RFs and narrowing of the RFs compared with the previous report. FM-ERG showed an almost extinguished response, and OCT images showed abnormalities of the outer nuclear and photoreceptor layers. Encircling and radial scleral buckling was performed. Four months postoperatively, the BCVA improved to 30/50, which corresponded to the recovery of the FM-ERG response and findings on the OCT images. One year and 3 months postoperatively, the BCVA recovered to 35/50 with repositioning of the fovea.
CONCLUSIONS: Simultaneous encircling and radial scleral buckling resulted in the recovery of both retinal function and structure in the current case and is a useful surgical option to treat late-onset progressive RFs due to intensification of traction.

Entities:  

Keywords:  Focal macular electroretinography; Optical coherence tomography; Retinal folds; Scleral buckling

Mesh:

Year:  2016        PMID: 27553815     DOI: 10.1007/s10633-016-9559-5

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  7 in total

Review 1.  Occult macular dystrophy.

Authors:  Yozo Miyake; Kazushige Tsunoda
Journal:  Jpn J Ophthalmol       Date:  2015-02-10       Impact factor: 2.447

2.  An easy method to raise the 25-gauge trocar and cannula system for retinopathy of prematurity-related lens-sparing vitrectomy.

Authors:  Naresh Babu; Parag K Shah; Venkatapathy Narendran; Narendran Kalpana; Ramasamy Kim
Journal:  Retina       Date:  2014-05       Impact factor: 4.256

3.  Clinical presentation of familial exudative vitreoretinopathy.

Authors:  Tushar M Ranchod; Lawrence Y Ho; Kimberly A Drenser; Antonio Capone; Michael T Trese
Journal:  Ophthalmology       Date:  2011-08-25       Impact factor: 12.079

4.  Clinical characteristics of occult macular dystrophy in family with mutation of RP1l1 gene.

Authors:  Kazushige Tsunoda; Tomoaki Usui; Tetsuhisa Hatase; Satoshi Yamai; Kaoru Fujinami; Gen Hanazono; Kei Shinoda; Hisao Ohde; Masakazu Akahori; Takeshi Iwata; Yozo Miyake
Journal:  Retina       Date:  2012-06       Impact factor: 4.256

5.  Clinical features of congenital retinal folds.

Authors:  Sachiko Nishina; Yumi Suzuki; Tadashi Yokoi; Yuri Kobayashi; Eiichiro Noda; Noriyuki Azuma
Journal:  Am J Ophthalmol       Date:  2011-08-26       Impact factor: 5.258

6.  COMPLETE RESOLUTION OF LARGE RETINAL FOLD AFTER TRANSECTION OF RETROLENTAL MEMBRANE DURING LENS-SPARING VITRECTOMY FOR RETINOPATHY OF PREMATURITY: A 15-YEAR FOLLOW-UP.

Authors:  Benjamin J Thomas; Yoshihiro Yonekawa; Michael T Trese
Journal:  Retin Cases Brief Rep       Date:  2016

7.  Congenital rotated macula with good vision and binocular function.

Authors:  Yumi Suzuki; Sachiko Nishina; Miina Hiraoka; Tadashi Yokoi; Noriyuki Azuma
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

  7 in total
  1 in total

1.  [Orbital cavity tumor with macular folds].

Authors:  M Kitsche; N Terai
Journal:  Ophthalmologe       Date:  2017-11       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.